The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway

Volume: 59, Issue: 1
Published: May 14, 2021
Abstract
Osteosarcoma (OS) metastasis and recurrence and multidrug resistance are three major obstacles in the clinic. New highly effective and low toxicity drugs for osteosarcoma are needed. The antitumoral efficacy of cetrimonium bromide (CTAB), a quaternary ammonium compound, is gradually being investigated. The aim of the present study was to investigate the effects of CTAB on OS cells and the underlying mechanisms. CTAB inhibited the proliferation...
Paper Details
Title
The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway
Published Date
May 14, 2021
Volume
59
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.